麻风病人体内抗酚糖脂-I(PGL-I)IgM 抗体水平与型别和细菌指数有关。为估价抗 PGL-I血清学试验作为监测治疗效果的可能性,作者在美国西图尔地区麻风门诊部对11例符合研究条件的病人连续测定其血清抗 PGL-I IgM 水平。所有病人按临床和组织学标准进行从 TT 到 LL 的5级分类。研究前均未接受抗麻风治疗,研究开始后接受氨苯 Anti-phenolic glycolipid-I (PGL-I) IgM antibody levels in leprosy patients were correlated with the type and bacterial index. To assess the potential of anti-PGL-I serological tests to monitor the efficacy of treatment, the authors consecutively measured serum levels of anti-PGL-I IgM in 11 leprosy clinics in the Western Region of the United States for patients eligible for the study. All patients were classified in 5 levels from TT to LL according to clinical and histological criteria. Before the study did not receive anti-leprosy treatment, the study started receiving aminobenzene